D-0507-2017 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0507-2017 was initiated by Dr. Reddy's Laboratories, Inc. on Feb 15, 2017 and is designated Class III. Reason for recall: Failed dissolution specifications - low dissolution results at S3 stage. The recall status is terminated (terminated Dec 19, 2018). Affected quantity: 12132 cartons.

Recall details

Product Type
Drugs
Report Date
Mar 8, 2017
Initiation Date
Feb 15, 2017
Termination Date
Dec 19, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12132 cartons

Product description

Zenatane (isotretinoin) capsules, 20 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 55111-136-81

Reason for recall

Failed dissolution specifications - low dissolution results at S3 stage.

Distribution pattern

U.S. Nationwide

Code information

Lot # KB50877, KB50878, Exp 11/17; KB50878, 01KB60251, Exp 3/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0507-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0507-2017. Report a data issue: hello@regdatalab.com.